Annual SGA
$129.62 M
+$26.91 M+26.20%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual SGA is $129.62 million, with the most recent change of +$26.91 million (+26.20%) on December 31, 2023.
- During the last 3 years, IBRX annual SGA has risen by +$58.30 million (+81.75%).
- IBRX annual SGA is now -4.17% below its all-time high of $135.26 million, reached on December 31, 2021.
Performance
IBRX SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$35.92 M
-$13.34 M-27.08%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly SGA is $35.92 million, with the most recent change of -$13.34 million (-27.08%) on September 30, 2024.
- Over the past year, IBRX quarterly SGA has dropped by -$13.34 million (-27.08%).
- IBRX quarterly SGA is now -27.08% below its all-time high of $49.25 million, reached on June 30, 2024.
Performance
IBRX Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$12.60 B
-$587.79 M-4.89%
September 30, 2024
Summary
- As of February 12, 2025, IBRX TTM SGA is -$12.60 billion, with the most recent change of -$587.79 million (-4.89%) on September 30, 2024.
- Over the past year, IBRX TTM SGA has dropped by -$12.76 billion (-8176.23%).
- IBRX TTM SGA is now -680.37% below its all-time high of -$1.62 billion.
Performance
IBRX TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
IBRX Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.2% | -27.1% | -8176.2% |
| 3 y3 years | +81.8% | +12.2% | -10000.0% |
| 5 y5 years | +179.0% | +12.2% | -10000.0% |
IBRX Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -4.2% | +26.2% | -27.1% | +116.7% | -72.4% | at low |
| 5 y | 5-year | -4.2% | +179.0% | -27.1% | +278.3% | -680.4% | at low |
| alltime | all time | -4.2% | +179.0% | -27.1% | +278.3% | -680.4% | at low |
ImmunityBio Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $35.92 M(-27.1%) | $160.16 M(+2.6%) |
| Jun 2024 | - | $49.25 M(+17.6%) | $156.06 M(+12.4%) |
| Mar 2024 | - | $41.88 M(+26.5%) | $138.83 M(+7.1%) |
| Dec 2023 | $129.62 M(+26.2%) | $33.11 M(+4.1%) | $129.62 M(+5.6%) |
| Sep 2023 | - | $31.82 M(-0.6%) | $122.72 M(+11.3%) |
| Jun 2023 | - | $32.02 M(-2.0%) | $110.22 M(+16.3%) |
| Mar 2023 | - | $32.68 M(+24.6%) | $94.78 M(-7.7%) |
| Dec 2022 | $102.71 M | $26.21 M(+35.8%) | $102.71 M(-1.6%) |
| Sep 2022 | - | $19.31 M(+16.5%) | $104.40 M(-9.0%) |
| Jun 2022 | - | $16.57 M(-59.2%) | $114.72 M(-12.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $40.61 M(+45.5%) | $130.59 M(-3.5%) |
| Dec 2021 | $135.26 M(+89.7%) | $27.91 M(-5.8%) | $135.26 M(+3.1%) |
| Sep 2021 | - | $29.63 M(-8.7%) | $131.23 M(+8.3%) |
| Jun 2021 | - | $32.45 M(-28.3%) | $121.20 M(+13.2%) |
| Mar 2021 | - | $45.27 M(+89.6%) | $107.10 M(+50.2%) |
| Dec 2020 | $71.32 M(+53.5%) | $23.88 M(+21.9%) | $71.32 M(+50.3%) |
| Sep 2020 | - | $19.60 M(+6.8%) | $47.44 M(+70.4%) |
| Jun 2020 | - | $18.35 M(+93.3%) | $27.84 M(+193.3%) |
| Mar 2020 | - | $9.49 M | $9.49 M |
| Dec 2019 | $46.46 M | - | - |
FAQ
- What is ImmunityBio annual SGA?
- What is the all time high annual SGA for ImmunityBio?
- What is ImmunityBio annual SGA year-on-year change?
- What is ImmunityBio quarterly SGA?
- What is the all time high quarterly SGA for ImmunityBio?
- What is ImmunityBio quarterly SGA year-on-year change?
- What is ImmunityBio TTM SGA?
- What is the all time high TTM SGA for ImmunityBio?
- What is ImmunityBio TTM SGA year-on-year change?
What is ImmunityBio annual SGA?
The current annual SGA of IBRX is $129.62 M
What is the all time high annual SGA for ImmunityBio?
ImmunityBio all-time high annual SGA is $135.26 M
What is ImmunityBio annual SGA year-on-year change?
Over the past year, IBRX annual SGA has changed by +$26.91 M (+26.20%)
What is ImmunityBio quarterly SGA?
The current quarterly SGA of IBRX is $35.92 M
What is the all time high quarterly SGA for ImmunityBio?
ImmunityBio all-time high quarterly SGA is $49.25 M
What is ImmunityBio quarterly SGA year-on-year change?
Over the past year, IBRX quarterly SGA has changed by -$13.34 M (-27.08%)
What is ImmunityBio TTM SGA?
The current TTM SGA of IBRX is -$12.60 B
What is the all time high TTM SGA for ImmunityBio?
ImmunityBio all-time high TTM SGA is -$1.62 B
What is ImmunityBio TTM SGA year-on-year change?
Over the past year, IBRX TTM SGA has changed by -$12.76 B (-8176.23%)